Cargando…

DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling

Recent evidence from a comprehensive genome analysis and functional studies have revealed that FOXM1 is a crucial metastatic regulator that drives cancer progression. However, the regulatory mechanism by which FOXM1 exerts its metastatic functions in cancer cells remains obscure. Here, we report tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, D W, Hui, W W Y, Wang, J J, Yung, M M H, Hui, L M N, Qin, Y, Liang, R R, Leung, T H Y, Xu, D, Chan, K K L, Yao, K-M, Tsang, B K, Ngan, H Y S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348575/ https://www.ncbi.nlm.nih.gov/pubmed/27593933 http://dx.doi.org/10.1038/onc.2016.307

Ejemplares similares

Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
por: Chan, David W., et al.
Publicado: (2012)

Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
por: Lok, Gabriel T. M., et al.
Publicado: (2011)

FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c
por: Lam, Andy K. Y., et al.
Publicado: (2013)

Overexpression of FOXG1 contributes to TGF-β resistance through inhibition of p21(WAF1/CIP1) expression in ovarian cancer
por: Chan, D W, et al.
Publicado: (2009)

Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells
por: Jiang, L, et al.
Publicado: (2017)

Correction: Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells
por: Jiang, L., et al.
Publicado: (2022)

Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway
por: Lee, I H, et al.
Publicado: (2014)

The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cells
por: Leung, T H-Y, et al.
Publicado: (2013)

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
por: Zhang, X, et al.
Publicado: (2017)

FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
por: Karadedou, Christina T., et al.
Publicado: (2011)

Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation
por: Ngan, Adaline Wan Ling, et al.
Publicado: (2019)

SUMOylation inhibits FOXM1 activity and delays mitotic transition
por: Myatt, S S, et al.
Publicado: (2014)

Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells
por: Xia, Wei, et al.
Publicado: (2017)

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
por: Zhao, Fung, et al.
Publicado: (2014)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

Dlx5 and Dlx6 can antagonize cell division at the G(1)/S checkpoint
por: MacKenzie, Rachel K., et al.
Publicado: (2019)

Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers
por: Yung, Mingo M. H., et al.
Publicado: (2022)

TGFβ1 Attenuates Expression of Prolactin and IGFBP-1 in Decidualized Endometrial Stromal Cells by Both SMAD-Dependent and SMAD-Independent Pathways
por: Kane, Nicole M., et al.
Publicado: (2010)

Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation
por: Xiang, D, et al.
Publicado: (2014)

First report of chronic implant-related septic arthritis and osteomyelitis due to Kytococcus schroeteri and a review of human K. schroeteri infections
por: Chan, J. F. W., et al.
Publicado: (2012)

The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3
por: Zhang, Zhenwang, et al.
Publicado: (2019)

MicroRNA‐539 functions as a tumour suppressor in prostate cancer via the TGF‐β/Smad4 signalling pathway by down‐regulating DLX1
por: Sun, Baogang, et al.
Publicado: (2019)

Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades
por: Siu, Michelle K. Y., et al.
Publicado: (2019)

MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis
por: Mak, Celia S. L., et al.
Publicado: (2017)

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance
por: Karunarathna, U, et al.
Publicado: (2016)

LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling
por: Niu, Ya, et al.
Publicado: (2016)

ChIP-seq Defined Genome-Wide Map of TGFβ/SMAD4 Targets: Implications with Clinical Outcome of Ovarian Cancer
por: Kennedy, Brian A., et al.
Publicado: (2011)

KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
por: Ali, A, et al.
Publicado: (2015)

Loss of dlx5a/dlx6a Locus Alters Non-Canonical Wnt Signaling and Meckel’s Cartilage Morphology
por: Yu, Emily P. Y., et al.
Publicado: (2023)

Regulation of Brn3b by DLX1 and DLX2 is required for retinal ganglion cell differentiation in the vertebrate retina
por: Zhang, Qi, et al.
Publicado: (2017)

TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma
por: Hsieh, Cheng-Han, et al.
Publicado: (2020)

Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression
por: Fung, Frederic K. C., et al.
Publicado: (2012)

Proinflammatory Cytokine Response and Viral Replication in Mouse Bone Marrow Derived Macrophages Infected with Influenza H1N1 and H5N1 Viruses
por: Chan, Renee W. Y., et al.
Publicado: (2012)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
por: Yuen, H-F, et al.
Publicado: (2010)

Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling
por: Cai, Patty C.H., et al.
Publicado: (2014)

Measuring subjective stress among young people in Hong Kong: validation and predictive utility of the single-item subjective level of stress (SLS-1) in epidemiological and longitudinal community samples
por: Wong, S. M. Y., et al.
Publicado: (2021)

A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR
por: Lau, T-S, et al.
Publicado: (2017)

The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment
por: Liang, Rui, et al.
Publicado: (2021)

Foxm1 is a critical driver of TGF‐β‐induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter
por: Song, Shuai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lh2kc86io47oq02977uuo8j1ft